Pharmacokinetics (PK) and Metabolism of FTY720 in Patients With Severe Renal Impairment and Healthy Matched Subjects.
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the pharmacokinetics of FTY720 and its metabolites in
patients with severe renal insufficiency and in matched, healthy volunteers. This study will
allow a better understanding of the effects of renal insufficiency on the disposition of
FTY720.